State Street
CLRB icon

State Street’s Cellectar Biosciences CLRB Stock Holding History

State Street’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,270
Closed -$40.4K – 4274
2025
Q1 		$40.4K Hold
4,270
– – ﹤0.01% 4125
2024
Q4 		$38.3K Buy
4,270
+376
+10% +$17.4K ﹤0.01% 4149
2024
Q3 		$250K Hold
3,894
– – ﹤0.01% 3775
2024
Q2 		$292K Buy
3,894
+380
+11% +$36.5K ﹤0.01% 3708
2024
Q1 		$420K Buy
3,514
+2,990
+571% +$324K ﹤0.01% 3696
2023
Q4 		$43.5K Hold
524
– – ﹤0.01% 4218
2023
Q3 		$41.5K Hold
524
– – ﹤0.01% 4330
2023
Q2 		$30.6K Hold
524
– – ﹤0.01% 4531
2023
Q1 		$22.6K Hold
524
– – ﹤0.01% 4670
2022
Q4 		$26.9K Hold
524
– – ﹤0.01% 4683
2022
Q3 		$53K Hold
524
– – ﹤0.01% 4645
2022
Q2 		$63K Buy
524
+23
+5% +$3.29K ﹤0.01% 4672
2022
Q1 		$103K Hold
501
– – ﹤0.01% 4631
2021
Q4 		$100K Hold
501
– – ﹤0.01% 4580
2021
Q3 		$139K Buy
501
+8
+2% +$2.44K ﹤0.01% 4469
2021
Q2 		$176K Buy
+493
New +$214K ﹤0.01% 4242
2018
Q3 		– Sell
-18
Closed -$34K – 3776
2018
Q2 		$34K Hold
18
– – ﹤0.01% 3701
2018
Q1 		$62K Hold
18
– – ﹤0.01% 3651
2017
Q4 		$75K Hold
18
– – ﹤0.01% 3620
2017
Q3 		$91K Hold
18
– – ﹤0.01% 3638
2017
Q2 		$89K Sell
18
-4
-18% -$21.9K ﹤0.01% 3561
2017
Q1 		$147K Buy
+22
New +$131K ﹤0.01% 3523

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

State Street's CLRB Position: Q2 2025 in Review

State Street sold out of Cellectar Biosciences (CLRB) in Q2 2025, closing a stake of 4,270 shares — an estimated $40.4K sold.

State Street first reported a position in CLRB in Q1 2017 and held it in 22 quarters. The position peaked at $420K in Q1 2024. 19 funds tracked by Wall St. Rank hold CLRB as of Q2 2025.

  • State Street reported no remaining Cellectar Biosciences position as of Q2 2025 after selling out during the quarter.
  • State Street sold 4,270 Cellectar Biosciences shares in Q2 2025, an estimated $40.4K.
  • State Street first reported a position in Cellectar Biosciences in Q1 2017 and held it in 22 quarters.
  • State Street's Cellectar Biosciences position peaked at $420K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.